Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Oct 31, 2016 | $28.0B |
| FY2017, ended Oct 29, 2017 | $43.0B |
| FY2018, ended Oct 28, 2018 | $42.4B |
| FY2019, ended Nov 3, 2019 | $55.2B |
| FY2020, ended Nov 1, 2020 | $70.8B |
| FY2021, ended Oct 31, 2021 | $105B |
| FY2022, ended Oct 30, 2022 | $118B |
| FY2023, ended Oct 29, 2023 | $101B |
| FY2024, ended Oct 27, 2024 | $111B |
| FY2025, ended Nov 2, 2025 | $125B |
| Trailing 12 months to Aug 2, 2026 (through Q3 FY2026) | $160B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Oct 31, 2016 | $26.6B |
| FY2017, ended Oct 29, 2017 | $29.7B |
| FY2018, ended Oct 28, 2018 | $37.4B |
| FY2019, ended Nov 3, 2019 | $39.3B |
| FY2020, ended Nov 1, 2020 | $35.5B |
| FY2021, ended Oct 31, 2021 | $44.0B |
| FY2022, ended Oct 30, 2022 | $52.6B |
| FY2023, ended Oct 29, 2023 | $61.3B |
| FY2024, ended Oct 27, 2024 | $51.7B |
| FY2025, ended Nov 2, 2025 | $45.7B |
| Trailing 12 months to Aug 2, 2026 (through Q3 FY2026) | $48.0B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Oct 31, 2016 | $1.52B | $3.12B |
| FY2017, ended Oct 29, 2017 | $2.16B | $1.60B |
| FY2018, ended Oct 28, 2018 | $2.37B | $926M |
| FY2019, ended Nov 3, 2019 | $3.25B | $2.29B |
| FY2020, ended Nov 1, 2020 | $2.75B | $6.66B |
| FY2021, ended Oct 31, 2021 | $5.96B | $6.88B |
| FY2022, ended Oct 30, 2022 | $7.13B | $3.56B |
| FY2023, ended Oct 29, 2023 | $10.2B | $7.09B |
| FY2024, ended Oct 27, 2024 | $7.10B | $7.59B |
| FY2025, ended Nov 2, 2025 | $5.03B | $6.10B |
| Trailing 12 months to Aug 2, 2026 (through Q3 FY2026) | $4.87B | $6.02B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Oct 31, 2016 | $4.34B |
| FY2017, ended Oct 29, 2017 | $9.33B |
| FY2018, ended Oct 28, 2018 | $3.90B |
| FY2019, ended Nov 3, 2019 | $3.86B |
| FY2020, ended Nov 1, 2020 | $7.07B |
| FY2021, ended Oct 31, 2021 | $8.02B |
| FY2022, ended Oct 30, 2022 | $4.77B |
| FY2023, ended Oct 29, 2023 | $7.46B |
| FY2024, ended Oct 27, 2024 | $7.32B |
| FY2025, ended Nov 2, 2025 | $8.28B |
| Trailing 12 months to Aug 2, 2026 (through Q3 FY2026) | $8.93B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Oct 31, 2016 | — |
| FY2017, ended Oct 29, 2017 | $25.9B |
| FY2018, ended Oct 28, 2018 | $27.2B |
| FY2019, ended Nov 3, 2019 | $30.2B |
| FY2020, ended Nov 1, 2020 | $41.3B |
| FY2021, ended Oct 31, 2021 | $43.8B |
| FY2022, ended Oct 30, 2022 | — |
| FY2023, ended Oct 29, 2023 | $17.9B |
| FY2024, ended Oct 27, 2024 | $13.5B |
| FY2025, ended Nov 2, 2025 | $13.8B |
| Trailing 12 months to Aug 2, 2026 (through Q3 FY2026) | $17.1B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 14.9% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Oct 31, 2016 | 317M |
| FY2017, ended Oct 29, 2017 | 323M |
| FY2018, ended Oct 28, 2018 | 319M |
| FY2019, ended Nov 3, 2019 | 313M |
| FY2020, ended Nov 1, 2020 | 313M |
| FY2021, ended Oct 31, 2021 | 307M |
| FY2022, ended Oct 30, 2022 | 298M |
| FY2023, ended Oct 29, 2023 | 280M |
| FY2024, ended Oct 27, 2024 | 272M |
| FY2025, ended Nov 2, 2025 | 270M |
| Trailing 12 months to Aug 2, 2026 (through Q3 FY2026) | 270M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Oct 31, 2016 | $205M | $70.6M |
| FY2017, ended Oct 29, 2017 | $6.00M | $68.0M |
| FY2018, ended Oct 28, 2018 | $958M | $84.0M |
| FY2019, ended Nov 3, 2019 | $1.25B | $82.0M |
| FY2020, ended Nov 1, 2020 | $750M | $81.0M |
| FY2021, ended Oct 31, 2021 | $2.54B | $82.0M |
| FY2022, ended Oct 30, 2022 | $3.60B | $85.0M |
| FY2023, ended Oct 29, 2023 | $7.22B | $130M |
| FY2024, ended Oct 27, 2024 | $4.01B | $208M |
| FY2025, ended Nov 2, 2025 | $1.14B | $151M |
| Trailing 12 months to Aug 2, 2026 (through Q3 FY2026) | $699M | $163M |
Valuation
At current price- Market Cap
- $172B
- P/E
- 35.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.6×
- Price / Book
- 6.2×
- EV / EBITDA
- 20.6×
Growth
Trailing 12 months- Revenue (TTM)
- $48.0B
- Revenue Growth YoY
- 8.0%
- Revenue CAGR 3Y
- −4.6%
- Revenue CAGR 5Y
- 5.2%
- EPS Growth YoY
- −6.1%
- Net Income Growth YoY
- −6.4%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 13.4%
- Net Margin
- 10.2%
- FCF Margin
- 12.5%
- Return on Equity
- 18.3%
Earnings
Trailing 12 months- Net Income
- $4.87B
- EPS (diluted)
- $17.99
- EBITDA
- $8.78B
- Operating Income
- $6.44B
Balance Sheet
As of Aug 2, 2026- Cash and cash equivalents
- $8.93B
- Total Debt
- $17.1B
- Net Debt
- $8.19B
- Total Assets
- $108B
- Total Liabilities
- $79.6B
- Shareholders' Equity
- $28.0B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $7.25B
- Capital Expenditure
- $1.22B
- Free Cash Flow
- $6.02B
Dividends and risk
Last 12 months- Dividend Yield
- 1.0%
- Dividend / Share
- $6.48
- Beta (5Y)
- 0.86
Every ratio is calculated from the company’s reported figures.